Relmada Therapeutics RLMD
NASDAQ RLMD
$3.29 +0.08 (+2.49%)
At close: Oct 22, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Revenue (2012 - 2023)

Updated

Relmada Therapeutics' Revenue was $5,129 in FY2013, down 35.4% from $7,941 in FY2012.

Analysis

Relmada Therapeutics (RLMD) Revenue (2012 - 2023) Analysis & Trends

  • Per Business Quant data, Revenue in earlier years was $7,941 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 25.40 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 16.99 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 15.38 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 7.80 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 15.03 Bn
10 Relmada Therapeutics 367.47 Mn -191.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.26 Mn
Sep 30, 2023 1.32 Mn
Jun 30, 2023 1.36 Mn
Mar 31, 2023 540,923.00
Dec 31, 2022 1.08 Mn
Sep 30, 2022 265,963.00
Jun 30, 2022 411,835.00
Mar 31, 2022 314,927.00
Dec 31, 2021 35,964.00
Sep 30, 2021 -39,301.00
Jun 30, 2021 -30.10 Mn
Mar 31, 2021 -35.76 Mn
Dec 31, 2020 224,268.00
Sep 30, 2020 363,300.00
Jun 30, 2020 -8.39 Mn
Mar 31, 2020 -13.19 Mn
Dec 31, 2019 849,211.00
Sep 30, 2019 37,916.00
Mar 31, 2019 15,939.00
Dec 31, 2018 -139,765.00
API Access

Relmada Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RLMD&period=max&api_key=YOUR_API_KEY